Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
Total Valuation
LifeMD has a market cap or net worth of $271.51M. The enterprise value is $200.46M.
Market Cap$271.51M
Enterprise Value$200.46M
Share Statistics
LifeMD has 44,583,687 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,583,687
Owned by Insiders17.79%
Owned by Institutions0.75%
Financial Efficiency
LifeMD’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee698.86K
Profits Per Employee-61.61K
Employee Count304
Asset Turnover<0.01
Inventory Turnover>-0.01
Valuation Ratios
The current PE Ratio of LifeMD is -10.80. LifeMD’s PEG ratio is 0.44.
PE Ratio-10.80
PS Ratio1.18
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF11.64
Price to Operating Cash Flow11.64
PEG Ratio0.44
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M and earned -18.88M in profits. Earnings per share was -0.53.
Revenue212.45M
Gross Profit242.40M
Operating Income-16.14M
Pretax Income-18.33M
Net Income-18.88M
EBITDA-6.65M
Earnings Per Share (EPS)-0.53
Cash Flow
In the last 12 months, operating cash flow was 17.51M and capital expenditures -8.82M, giving a free cash flow of 8.70M billion.
Operating Cash Flow17.51M
Free Cash Flow8.70M
Free Cash Flow per Share0.20
Dividends & Yields
LifeMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.56
52-Week Price Change-48.69%
50-Day Moving Average5.62
200-Day Moving Average5.51
Relative Strength Index (RSI)62.22
Average Volume (3m)798.19K
Important Dates
LifeMD upcoming earnings date is May 9, 2025, TBA Not Confirmed.
Last Earnings DateMar 10, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend Date―
Financial Position
LifeMD as a current ratio of 0.81, with Debt / Equity ratio of -277.43%
Current Ratio0.81
Quick Ratio0.76
Debt to Market Cap74.63K
Net Debt to EBITDA2.97M
Interest Coverage Ratio0.00
Taxes
In the past 12 months, LifeMD has paid -402.00K in taxes.
Income Tax-402.00K
Effective Tax Rate0.02
Enterprise Valuation
LifeMD EV to EBITDA ratio is 2.97M, with an EV/FCF ratio of -1.13M.
EV to Sales-93.13K
EV to EBITDA2.97M
EV to Free Cash Flow-1.13M
EV to Operating Cash Flow-1.13M
Balance Sheet
LifeMD has $35.00M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$19.79M billion.
Cash & Marketable Securities$35.00M
Total Debt$0.00
Net Cash-$19.79M
Net Cash Per Share-$0.44
Tangible Book Value Per Share-$147.49K
Margins
Gross margin is 92.21%, with operating margin of -7.60%, and net profit margin of -8.89%.
Gross Margin92.21%
Operating Margin-7.60%
Pretax Margin-8.63%
Net Profit Margin-8.89%
EBITDA Margin-3.13%
EBIT Margin-7.60%
Analyst Forecast
The average price target for LifeMD is $11.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$11.33
Price Target Upside86.04% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast39.27%
EPS Growth Forecast23.49%